OPGX — Optigenex Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Optigenex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2006 December 31st | 2007 December 31st | 2009 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | 10KSB | 10KSB | PRESS |
Standards: | USG | USG | — |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 0.301 | 0.466 | 0.688 |
Cost of Revenue | |||
Gross Profit | -1.22 | -0.103 | 0.5 |
Selling / General / Administrative Expenses | |||
Research And Development | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Total Operating Expenses | -2.33 | 0.566 | 1.01 |
Operating Profit | 2.63 | -0.1 | -0.319 |
Total Net Non Operating Interest Income / Expense | |||
Net Income Before Taxes | -7.36 | -2.9 | -0.702 |
Provision for Income Taxes | |||
Net Income After Taxes | -7.36 | -2.9 | -0.702 |
Net Income Before Extraordinary Items | |||
Net Income | -7.36 | -2.9 | -0.702 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Dilution Adjustment | |||
Diluted Net Income | -7.36 | -2.9 | -0.702 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -194,884 | -36,983 | -1,554 |
Dividends per Share |